Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis

by Nigel Cook, Andreas Geier, Andreas Schmid, Gideon Hirschfield, Achim Kautz, Jörn M. Schattenberg, Maria-Magdalena Balp
Published 2020-04-01

The Patient Perspectives on Future Therapeutic Options in NASH and Patient Needs

by Nigel Cook, Andreas Geier, Andreas Schmid, Gideon Hirschfield, Achim Kautz, Jörn M. Schattenberg, Maria-Magdalena Balp
Published 2019-04-01

Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis

by Andrea Dennis, Matt D. Kelly, Carolina Fernandes, Sofia Mouchti, Jonathan A. Fallowfield, Gideon Hirschfield, Michael Pavlides, Michael Pavlides, Michael Pavlides, Stephen Harrison, Stephen Harrison, Manu V. Chakravarthy, Rajarshi Banerjee, Arun Sanyal
Published 2021-01-01

The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation.

by Konstantin Knoblich, Sara Cruz Migoni, Susan M Siew, Elizabeth Jinks, Baksho Kaul, Hannah C Jeffery, Alfie T Baker, Muath Suliman, Katerina Vrzalikova, Hisham Mehenna, Paul G Murray, Francesca Barone, Ye H Oo, Philip N Newsome, Gideon Hirschfield, Deirdre Kelly, Steven P Lee, Biju Parekkadan, Shannon J Turley, Anne L Fletcher
Published 2018-09-01

Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis

by Emma L. Shepherd, Raquel Saborano, Ellie Northall, Kae Matsuda, Hitomi Ogino, Hiroaki Yashiro, Jason Pickens, Ryan E. Feaver, Banumathi K. Cole, Stephen A. Hoang, Mark J. Lawson, Matthew Olson, Robert A. Figler, John E. Reardon, Nobuhiro Nishigaki, Brian R. Wamhoff, Ulrich L. Günther, Gideon Hirschfield, Derek M. Erion, Patricia F. Lalor
Published 2021-04-01